A guide to selecting high-performing antibodies for GPNMB (UniProt ID: Q14956) for use in western blot, immunoprecipitation, and immunofluorescence
This report provides a guide for selecting high-quality commercial antibodies against the transmembrane glycoprotein NMB (GPNMB) for applications in western blot, immunoprecipitation, and immunofluorescence, using a knockdown cell line as an isogenic control. This research was partially supported by the Emory-Sage-SGC TREAT-AD center, established by the National Institutes of Aging under award number U54AG065187.
Institutions
- Montreal Neurological Institute and Hospital (CA)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2024-12-11
- DOI
- https://doi.org/10.5281/zenodo.14393182
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00